Imara Announces FDA Clearance of Investigational New Drug Application (IND) for Tovinontrine (IMR-687) for Heart Failure with Preserved Ejection Fraction (HFpEF)
25th January 2022
Portfolio
This post references, or is about Imara. Find out more by clicking below
Print Article
Email Article
Save Article
